Recently Featured

WHO Intensifies Ebola-Curbing Efforts Through Drug Trial and Diagnostic Rollout

August 10, 2026
The World Health Organization (WHO) is advancing its response to Ebola by sponsoring a clinical trial aimed at evaluating potential treatments for the Bundibugyo virus, while simultaneously adding the first Ebola diagnostic test to its emergency use list. This dual approach highlights the organization’s commitment to addressing the ongoing public health challenge posed by Ebola…

SK bioscience to lead Gates Foundation-funded ROTOR project

August 10, 2026
SK bioscience is set to lead the Gates Foundation-funded ROTOR project, an AI-based platform aimed at reducing uncertainty in vaccine-development decisions. This initiative underscores the growing importance of artificial intelligence in streamlining vaccine research and development, particularly in a landscape that demands rapid responses to emerging health threats. The ROTOR project is designed to leverage…

UK Guidance on Best Practices for Labelling and Packaging of Medicines Released

August 10, 2026
The UK government has released new guidance outlining best practices for the labelling and packaging of medicines, clarifying the legal framework established under UK legislation. This comprehensive document serves as a crucial resource for pharmaceutical professionals involved in regulatory compliance, quality assurance, and product development. It emphasizes the importance of accurate and clear labelling, which…

European Commission Approves Novartis’ Itvisma to Treat SMA

August 10, 2026
The European Commission has granted approval for Novartis’ Itvisma, marking a significant advancement in the treatment landscape for spinal muscular atrophy (SMA). This therapy is specifically indicated for children aged two years and older, as well as teenagers and adults diagnosed with 5q SMA who possess a bi-allelic mutation in the SMN1 gene. This approval…

Ongoing Cases